Robert J. Wechsler-Reya, Ph.D.

Affiliations: 
2001-2010 Duke Medical School, Durham, NC, United States 
 2010- Tumor Initiation & Maintenance Sanford Burnham Prebys Medical Discovery Institute 
Area:
Cerebellar development, brain tumors
Website:
http://www.wechsler-reya.org
Google:
"Robert Wechsler-Reya"
Mean distance: 16.24 (cluster 32)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yang Y, Valdés-Rives SA, Liu Q, et al. (2024) Thyroid Hormone Suppresses Medulloblastoma Progression Through Promoting Terminal Differentiation of Tumor Cells. Biorxiv : the Preprint Server For Biology
Gold MP, Ong W, Masteller AM, et al. (2024) Developmental basis of SHH medulloblastoma heterogeneity. Nature Communications. 15: 270
Chapman OS, Luebeck J, Sridhar S, et al. (2023) Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma. Nature Genetics
Rajbhandari N, Hamilton M, Quintero CM, et al. (2023) Single-cell mapping identifies MSI cells as a common origin for diverse subtypes of pancreatic cancer. Cancer Cell
Kuzuoglu-Ozturk D, Aksoy O, Schmidt C, et al. (2022) N-myc mediated translation control is a therapeutic vulnerability in medulloblastoma. Cancer Research
Borgenvik A, Holmberg KO, Bolin S, et al. (2022) Dormant SOX9-positive cells facilitate MYC-driven recurrence of medulloblastoma. Cancer Research
Foster JB, Griffin C, Rokita JL, et al. (2022) Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors. Journal For Immunotherapy of Cancer. 10
Hendrikse LD, Haldipur P, Saulnier O, et al. (2022) Failure of human rhombic lip differentiation underlies medulloblastoma formation. Nature
Leskoske KL, Garcia-Mansfield K, Sharma R, et al. (2022) Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived Xenografts. Journal of Proteome Research
Zagozewski J, Borlase S, Guppy BJ, et al. (2022) Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression. Communications Biology. 5: 697
See more...